Luoxin Pharmaceuticals Group Stock Co., Ltd.

SZSE:002793 Stock Report

Market Cap: CN¥4.9b

Luoxin Pharmaceuticals Group Stock Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 002793?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme18,219,5031.72%
Individual Insiders125,869,41411.9%
Institutions180,667,68217%
Private Companies297,706,70928%
General Public439,097,31741.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 58.64% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
22.3%
Shandong Luoxin Holdings Co., Ltd
236,955,520CN¥1.1b0%no data
9.45%
Xiubao Fang
100,294,266CN¥460.4m0%no data
4.39%
Ally Bridge Group
46,609,537CN¥213.9m0%10.67%
3.93%
Deyi Investment Management (Beijing) Co., Ltd.
41,692,359CN¥191.4m0%no data
3.37%
Karamay Deyi Hengjia Equity Investment Limited Partnership Enterprise
35,789,757CN¥164.3m0%no data
2.35%
Karamay Deyi Xinhua Equity Investment
24,961,414CN¥114.6m0%no data
2.18%
Beijing Shunzhi Asset Management Co., Ltd.
23,099,570CN¥106.0m0%61.43%
2.07%
Ningbo Ningju Asset Management Center (Limited Partnership)
22,000,000CN¥101.0m0%3.66%
1.97%
Donghui Fang
20,884,500CN¥95.9m0%no data
1.89%
Zircon Private Securities Fund Management Hainan Co.,Ltd.
20,065,900CN¥92.1m0%no data
1.72%
Luoxin Pharmaceuticals Group Stock Co., Ltd., ESOP
18,219,503CN¥83.6m0%no data
1.54%
GF Fund Management Co., Ltd.
16,364,700CN¥75.1m-37.7%0.02%
0.44%
Zhenteng Liu
4,689,648CN¥21.5m0%no data
0.33%
The Vanguard Group, Inc.
3,476,729CN¥16.0m0%no data
0.27%
China Universal Asset Management Company Ltd.
2,839,000CN¥13.0m0%0.01%
0.13%
Hwabao WP Fund Management Co., Ltd
1,430,200CN¥6.6m0%0.01%
0.1%
Fuanda Fund Management Co. Ltd.
1,107,000CN¥5.1m0%0.31%
0.098%
Dimensional Fund Advisors LP
1,038,597CN¥4.8m-3%no data
0.06%
UBS SDIC Fund Management Co., Ltd.
638,400CN¥2.9m0%0.01%
0.021%
State Street Global Advisors, Inc.
222,700CN¥1.0m0%no data
0.0055%
Hongde Fund Management Co., Ltd.
58,700CN¥269.5k0%no data
0.0016%
Wanjia Asset Management Co., Ltd.
16,700CN¥76.5k0%no data
0.00069%
Oriental Alpha Fund Management Co., Ltd.
7,300CN¥33.6k0%no data
0.00009%
Lijun Dong
1,000CN¥4.4k0%no data
0.00002%
First State Cinda Fund Management Company Limited
200CN¥974.50%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/07 13:15
End of Day Share Price 2025/01/07 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Luoxin Pharmaceuticals Group Stock Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jayaprabha DhavaleVirtua Research Inc.